IP Library › Assignment 025317/0170
Patent Assignment
Reel/Frame 025317/0170

Security Agreement

Recorded: 2010-11-04 Received: 2010-11-04 Pages: 20
Assignor
EXAGEN DIAGNOSTICS, INC.
Executed: 2010-10-12
Assignees
NEW MEXICO MEZZANINE PARTNERS, L.P.
518 OLD SANTA FE TRAIL, SUITE ONE #323, SANTA FE, NM, 87505, UNITED STATES
NEW MEXICO CO-INVESTMENT FUND, L.P.
301 GRIFFIN STREET, SANTA FE, NM, 87501, UNITED STATES
Covered Properties (18)
Biomarkers for Ulcerative Colitis and Crohn's Disease
Application: 61/322,397 →
Biomarkers for Inflammatory Bowel Disease and Irritable Bowel Syndrome
Application: 12/749,033 →
Biomarkers for Inflammatory Bowel Disease and Irritable Bowel Syndrome
Application: 12/749,012 →
Biomarkers for Inflammatory Bowel Disease and Irritable Bowel Syndrome
Application: 12/710,830 →
Methods and Devices Relating to Estimating Classifier Performance
Application: 12/502,979 →
Acute Myelogenous Leukemia Biomarkers
Application: 12/478,930 →
Compositions and methods for glioma classification
Application: 12/387,555 →
Biomarkers for Inflammatory Bowel Disease and Irritable Bowel Syndrome
Biomarkers for Inflammatory Bowel Disease and Irritable Bowel Syndrome
Application: 12/403,810 →
Biomarkers for Inflammatory Bowel Disease and Irritable Bowel Syndrome
Application: 12/403,719 →
Acute Myelogenous Leukemia Biomarkers
Application: 11/417,450 →
Methods for RNA fluorescence in situ hybridization
Application: 11/159,799 →
Unique sequence hybridization probes (USP)
Application: 11/112,926 →
Compositions and methods for breast cancer prognosis
Application: 11/112,908 →
Breast cancer gene expression biomarkers
Application: 11/112,944 →
Compositions for Glioma Classification
Application: 10/981,277 →
Methods for in situ hybridization without the need for competitior DNA
Application: 10/833,954 →
Methods and Devices Relating to Estimating Classifier Performance
Application: 10/109,094 →